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http://dx.doi.org/10.1016/j.stemcr.2016.05.007SUMMARYThe capacity of hematopoietic stem cells (HSC) to generate B lymphocytes declines with age, contributing to impaired immune function
in the elderly. Here we show that the histone methyltransferase SUV39H1 plays an important role in human B lymphoid differentiation
and that expression of SUV39H1 decreaseswith age in bothhuman andmouseHSC, leading to a global reduction inH3K9 trimethylation
and perturbed heterochromatin function. Further, we demonstrate that SUV39H1 is a target of microRNAmiR-125b, a known regulator
of HSC function, and that expression of miR-125b increases with age in human HSC. Overexpression of miR-125b and inhibition of
SUV39H1 in young HSC induced loss of B cell potential. Conversely, both inhibition of miR-125 and enforced expression of
SUV39H1 improved the capacity of HSC from elderly individuals to generate B cells. Our findings highlight the importance of hetero-
chromatin regulation in HSC aging and B lymphopoiesis.INTRODUCTION
All myeloid and lymphoid blood cell lineages are continu-
ally replenished throughout adult life from a reservoir of
rare multipotent hematopoietic stem cells (HSC) residing
in the bone marrow. Studies in both humans and mice
have shown that HSC are not constant throughout life
(Chambers et al., 2007; Dykstra et al., 2011; Flach et al.,
2014; Kuranda et al., 2011; Lescale et al., 2010; Pang
et al., 2011; Rossi et al., 2005). There is an increase in the
number of phenotypically defined HSC with age, but the
stem cells that accumulate exhibit a diminished long-
term reconstitution potential as well as a cell-intrinsic
reduction in their capacity to generate immune-competent
B lymphocytes, leading to a myeloid-biased differentiation
output. This age-associated skewing of HSC differentiation
potential from lymphoid to myeloid lineages, and the
resultant decreased output of naive B cells, leads to a
decline in antibody diversity and is believed to contribute
to the general depletion of immune function observed in
the elderly (reviewed in Denkinger et al., 2015). HSC aging
is driven by both cell-extrinsic alterations in the stem cell
niche and systemic signals, as well as changes intrinsic to
the stem cells themselves (reviewed in Garrick et al.,
2015; Geiger et al., 2013), including widespread changes
in gene-expression patterns (Chambers et al., 2007; Flach970 Stem Cell Reports j Vol. 6 j 970–984 j June 14, 2016 j ª 2016 The Autho
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While the molecular triggers for these transcriptomic
and functional changes are still incompletely understood,
recent studies in mouse HSC have demonstrated that aging
is associated with alterations in the DNA methylation and
histone modification profiles (Beerman et al., 2013; Sun
et al., 2014), suggesting that disruption of the normal epige-
netic state is an important factor in the aging HSC pheno-
type. One key component of the epigenetic landscape is
the formationofdomainsofheterochromatin.These regions
of compacted and transcriptionally repressive chromatin are
critical for diverse aspects of nuclear biology, including the
regulation of gene-expression patterns, the transcriptional
silencing of genomic repeats, and the maintenance of
genome stability, aswell as normal centromere and telomere
function (Bulut-Karslioglu et al., 2014; Grewal and Jia, 2007;
Peters et al., 2001; Schoeftner and Blasco, 2009). One of the
principal enzymes involved in the formation of heterochro-
matin is SUV39H, a familyof twohistonemethyltransferases
(SUV39H1/KMT1A and SUV39H2/KMT1B) that catalyze
tri-methylation of lysine 9 of histone H3 (H3K9me3) (Peters
et al., 2001). The H3K9me3 histone modification is recog-
nized and bound by members of the heterochromatin
protein 1 (HP1) family (Lachner et al., 2001), critical
adaptor proteins that coordinate chromatin compaction byrs.
ecommons.org/licenses/by-nc-nd/4.0/).
undergoing self-association as well as recruiting histone
deacetylases, DNA methyltransferases, and structural RNAs
(reviewed in Maison and Almouzni, 2004). Consistent
with a crucial role for heterochromatin during differentia-
tion and development, it has been shown that SUV39H1-
mediated H3K9me3 regulates lineage commitment during
early mouse development by repressing lineage-inappro-
priate genes (Alder et al., 2010) and that depletion of
SUV39H gives rise to pre- and postnatal developmental de-
fects and lethality inmice (Peters et al., 2001). Accumulating
evidence suggests that SUV39Hmay also regulate various as-
pects ofhematopoiesis. The SUV39H1/HP1 regulatory axis is
important to maintain cellular fate following commitment
to the T helper 2 (TH2) lymphocyte lineage (Allan et al.,
2012). Further, deletion of Suv39h inmice leads to the devel-
opment of late-onset B cell lymphomas (Peters et al., 2001),
whileoverexpressionof SUV39Hleads to impairederythroid
differentiation (Czvitkovich et al., 2001). However, at pre-
sent the role of SUV39H and heterochromatin structure in
HSC aging and the regulation of differentiation potential
has not been investigated directly.
In this study we show that SUV39H1 plays an impor-
tant role in the differentiation of human HSC toward
the B cell lineage. Expression of SUV39H1 in HSC de-
clines with age, leading to relaxation of heterochromatin
and derepression of genomic repeat elements. The age-
associated decrease in SUV39H1 in human HSC correlates
with an increase in expression of miR-125b, a microRNA
(miRNA) which has been shown previously to target
SUV39H1 and is a key regulator of HSC self-renewal
and differentiation potential. Both inhibition of miR-
125 and overexpression of SUV39H1 improved the B
cell output of HSC from elderly individuals. Our findings
support previous studies implicating the loss of hetero-
chromatin as a key hallmark of aging and suggest
that this axis may be targeted to improve HSC function
with age.RESULTS
SUV39H1 Is Highly Expressed in Human HSC and Is
Important during B Cell Generation
The SUV39H family comprises two members, SUV39H1
and SUV39H2. SUV39H1 is the predominant form ex-
pressed in both human cord blood and bone marrow
CD34+CD38 HSC, as has previously been observed in
mouse long-term repopulating HSC (LT-HSC) (Figures
S1A and S1B; Sun et al., 2014). Analysis of SUV39H1
expression during human hematopoietic differentiation
revealed that SUV39H1 is highly expressed in the primi-
tive HSC compartment and that its expression decreases
during myeloid differentiation, but is maintained inbone marrow B lymphoid cells (Figure 1A). To investigate
the role of SUV39H1 during HSC differentiation, we
treated bone marrow CD34+ progenitors with chaetocin,
an inhibitor of SUV39H (Greiner et al., 2005), and
analyzed the effects on B lymphoid and myeloid output
in in vitro differentiation assays. Treatment with chaeto-
cin induced a significant decrease in the global levels of
H3K9me3 in CD34+CD38 HSC as assessed by fluores-
cence-activated cell sorting (FACS) analysis, while histone
H3 acetylation (H3ac) levels remained unchanged,
showing that SUV39H1 is important for the maintenance
of H3K9me3 levels in HSC (Figures 1B and S2A). We
found that chaetocin decreased the generation of B line-
age cells following in vitro differentiation, whereas the
production of myeloid colonies was not affected (Fig-
ure 1C). Treatment with chaetocin (10–100 mM) of
CD34+CD38 HSC, CD34+CD33+ myeloid progenitors,
or CD34+CD19+ B lymphoid progenitors did not lead to
increased apoptosis as measured by Annexin V staining,
indicating that loss of B cell generation observed in these
differentiation assays was not due to treatment-related
toxicity (data not shown). As chaetocin may also inhibit
the activity of other histone lysine methyltransferases,
to confirm that the decline in B cell differentiation was
indeed due to an effect on SUV39H1, human CD34+
stem and progenitor cells were transfected with small
interfering RNA (siRNA) targeting SUV39H1, or non-
silencing control (Figures 1D and S2B–S2D). Knockdown
of SUV39H1 mRNA and protein relative to control-treated
cells was confirmed by qRT-PCR and FACS analysis,
respectively (Figures S2C and S2D). In vitro differentiation
assays performed on siRNA-transfected cells revealed that
knockdown of SUV39H1 specifically decreased B cell dif-
ferentiation, without affectingmyeloid output (Figure 1D),
similar to the result observed with chaetocin. In contrast,
no effect on B cell differentiation was observed using the
same concentration range of the control, non-targeting
siRNA (Figure S2E). Taken together, these results indicate
that SUV39H1 is highly expressed in HSC and is an
important factor for human B lymphopoiesis.
Decreased SUV39H1 and Global Levels of H3K9me3 in
HSC with Age
Aging is associated with functional changes in the HSC
compartment and, in particular, the capacity of HSC to
generate B cells is decreased with age in both mice and hu-
mans (Dykstra et al., 2011; Kuranda et al., 2011; Lescale
et al., 2010; Pang et al., 2011; Rossi et al., 2005).Our observa-
tions that SUV39H1 ishighly expressed in theHSCcompart-
mentand is required forB cell differentiationpromptedus to
investigate whether expression of this factor is altered with
age. We found that expression of SUV39H1 is significantly
decreased in human CD34+CD38 HSCs isolated from theStem Cell Reports j Vol. 6 j 970–984 j June 14, 2016 971
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Figure 1. The Histone Methyltransferase SUV39H1 Is Critical for B Lymphoid but Not Myeloid Differentiation
(A) qRT-PCR analysis of the expression of SUV39H1 in the populations indicated, isolated from human bone marrow. Values shown are
normalized to HPRT1 expression (mean + SD; nR 4 for each population).
(B) FACS analysis of histone H3K9me3 and H3ac in CD34+CD38 HSC following treatment of CD34+ cells with 10 mM chaetocin or carrier
(DMSO) for 2 hr (mean + SD; nR 4). Results are normalized with respect to the mean fluorescence intensity of control-treated cells.
(C) In vitro differentiation of control or chaetocin-treated CD34+ cells. B cell differentiation was measured as the percentage of wells
containing B lymphocytes (CD45+CD19+CD33CD34) 4 weeks after plating limiting numbers of CD34+ cells on MS5 stromal layers. Myeloid
differentiation is expressed as the total number of colonies observed after 10 days in methylcellulose cultures. Results are normalized with
respect to untreated cells (mean + SEM; nR 3).
(D) In vitro differentiation of CD34+ cells transfected with SUV39H1 siRNA or non-targeting control. B lymphoid and myeloid differen-
tiation was assessed as described in (C) (mean + SEM; nR 3).
*p < 0.05; **p < 0.01. See also Figures S1 and S2.bonemarrowofelderly individuals (>70years) relative to the
level observed in the same population from young individ-
uals (<35 years) (Figures 2A, S3A, and S3B). In contrast to
SUV39H1, expression of SETDB1/KMT1E, a methyltransfer-
ase which also catalyzes H3K9me3 (Schultz et al., 2002)
did not change with age in HSC (Figure S3B). In order to
investigate whether the observed decrease of SUV39H1
affected global levels of H3K9me3, we measured this modi-
fication by intracellular FACS in CD34+38 HSC isolated
from young and old individuals. We found that aging was
associated with a reduction in the levels of H3K9me3, while
no change was observed in the global levels of H3ac (Fig-
ure 2B). Consistent with these findings in human HSCs,972 Stem Cell Reports j Vol. 6 j 970–984 j June 14, 2016we observed a similar decline with age in the expression
of Suv39h1 in both the mouse LinSCA1+c-KIT+ (LSK) pop-
ulation of hematopoietic stem and progenitor cells, as
well as in the more primitive LT-HSC (LinSCA1+c-KIT+
FLT3CD34CD150+) (Figures2CandS3C).Within themu-
rine HSC compartment, reduced expression of Suv39h1was
associatedwith adecrease in theglobal levels ofH3K9me3as
assessed by immunofluorescence in LT-HSC and short-term
repopulating HSC (ST-HSC; LinSCA1+c-KIT+FLT3CD34+)
(Figure 2D). In ST-HSC, where a higher proportion of cells
have exited quiescence (Wilson et al., 2008), we also
observed a decrease with age in the level of the heterochro-
matin-binding protein HP1a, suggesting that downstream
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changes in chromatin are more strongly detected once the
stemcells start cycling (Figure2E).These resultsdemonstrate
that aging is associated with reduced SUV39H1 expression
and decreased levels of H3K9me3 in the HSC compartment,
indicative of perturbed heterochromatin.
Decreased Expression of SUV39H1 in HSC Results in
Derepression of Genomic Repeats with Age
To investigate the effects of these age-associated changes
on heterochromatin function in HSC, we analyzed the
expression of a number of genomic repetitive elements
which are normally repressed by the H3K9me3/HP1 het-
erochromatic axis (Sharma et al., 2012). In human HSC,
aging was associated with increased expression of several
of these repeat elements, including Satellite II tandem
pericentromeric repeats as well as certain dispersed hu-
man endogenous retrovirus elements (HERV-K/env102
and HERV-H/env62) (Figure 3A). Consistent with these re-
sults, we found that severalmouse endogenous retroviruses
and interspersed repeats previously shown to be controlled
by Suv39h-mediated H3K9me3 in embryonic stem cells
(particularly active LINE1 family members L1_A and
L1_Tf as well as intracisternal A-type particles [IAP]) (Bu-
lut-Karslioglu et al., 2014) were also upregulated with age
in murine LSK cells (Figure 3B). The transcriptional dere-
pression of interspersed repeats has also been reported
previously in LT-HSC of old mice (Sun et al., 2014). Similar
to these changes observed with age, expression of LINE1
and IAP elements was also upregulated in LSK cells of
Suv39h1null mice (Figures 3C and S4A), indicating that
SUV39H1-mediated H3K9me3 is indeed required for the
normal transcriptional repression of these repeats in the
HSC compartment. Consistent with previous observations,
no significant differences were observed between the B cell
compartments of Suv39h1null and wild-type (WT) mice
under homeostatic conditions (data not shown and Allan
et al., 2012; Braig et al., 2005; Peters et al., 2001). How-
ever, competitive transplantation experiments revealedFigure 2. Age-Related Decrease in SUV39H1 Expression and Histo
(A) qRT-PCR analysis of the expression of SUV39H1 in CD34+CD38
(>70 years) individuals. Expression relative to ACTB was normalized to
nR 6, with each sample comprising a pool of two to four individual
(B) FACS analysis of H3K9me3 and H3ac in CD34+CD38 HSC isolated f
SD; nR 4).
(C) qRT-PCR analysis of the expression of Suv39h1 in LT-HSC isolated f
C57BL/6 mice. Expression relative to Actb was normalized to the mean
comprising a pool of four young or old mice).
(D and E) Immunofluorescence analysis of H3K9me3 (D) and HP1a (E)
mice. The left panel shows representative images (scale bars, 2 mm) an
fluorescence (integrated density) of a minimum of 60 cells (bars indi
experiments.
*p < 0.05; **p < 0.01. See also Figure S3.
974 Stem Cell Reports j Vol. 6 j 970–984 j June 14, 2016that Suv39h1null bone marrow progenitors exhibited a
myeloid-biased engraftment potential, a characteristic
of aged HSC (Figure S4B). Interestingly, Suv39h1null
LSK cells also showed elevated expression of the Selp
gene encoding P-SELECTIN, a hallmark gene whose expres-
sion is increased with age in both human (Pang et al.,
2011) and mouse HSC (Flach et al., 2014; Rossi et al.,
2005; Sun et al., 2014) (Figure S4C). These results
support the idea that the age-associated decrease in
expression of SUV39H1 in HSC leads to relaxation of het-
erochromatin structure and to transcriptional derepres-
sion, including upregulation of certain genomic repeat
elements.
miR125b Increases with Age and Targets SUV39H1
in HSC
We next investigated the mechanism responsible for
the age-associated decline in expression of SUV39H1.
miRNAs are known to play important roles in controlling
hematopoietic differentiation programs (Baltimore et al.,
2008) and have more recently been implicated in HSC ag-
ing (Mehta et al., 2015). We used miRWalk2.0 (Dweep
et al., 2011) to search for miRNAs that are predicted to
target the human SUV39H1 transcript. Among the most
significant hits were members of the miR-125 family
(miR-125a and miR-125b), which are predicted to bind
to a perfect 8-mer target site that has been evolutionarily
conserved within the 30 UTR of the SUV39H1 transcript
(Figure 4A). This was of particular interest, since members
of this family have been shown to be critical regulators of
HSC self-renewal and differentiation potential in mice
(Guo et al., 2010; O’Connell et al., 2010; Ooi et al.,
2010). Notably, overexpression of miR-125 has been re-
ported to lead to a myeloid-biased differentiation of
HSC, similar to that observed with age (Gerrits et al.,
2012; Guo et al., 2010; O’Connell et al., 2010; Wojtowicz
et al., 2014). The miR-125 family consists of three mature
miRNAs (miR-125b-1, miR-125b-2, and miR-125a), whichne H3K9me3 Levels in Human and Mouse HSC
HSC pooled from bone marrows of young (<35 years) and elderly
the mean value observed in HSC from young individuals (mean ± SD;
s).
rom young (<35 years) and elderly (>70 years) individuals (mean +
rom bone marrows of young (2–3 months) and old (20–22 months)
value observed in young mice (mean ± SD; nR 4, with each sample
in LT-HSC and ST-HSC isolated from bone marrows of young and old
d the graphs in the right panel show background-corrected total cell
cate mean ± SD). The result is a representative of two independent
A B C
Figure 3. Expression of Genomic Repeat Elements in HSC Is Upregulated with Age and in the Absence of SUV39H1
(A) qRT-PCR analysis of the expression of interspersed (HERV-H/env62, HERV-K/env102, HERV-H/env59, HERV-H/env60) and pericentro-
meric (Satellite II, a Satellite) repetitive elements in CD34+CD38 HSC from young (<35 years) and elderly (>70 years) individuals. For each
repeat, expression relative to RPLPO has been normalized to the mean value observed in young individuals (mean ± SD; nR 4).
(B) qRT-PCR analysis of the expression of LINE1 (L1-A, L1-Tf, and L1-prom), IAP and SINE B2 (B2) elements and major satellite repeats in
LSK cells isolated from bone marrows of young (2–3 months) and old (20–22 months) C57BL/6 mice. Expression of each repeat relative to
Actb has been normalized to the mean value observed in LSK of young mice (mean ± SD; nR 3 individual mice).
(C) qRT-PCR analysis of the same genomic repeats as in (B) in LSK cells isolated from bone marrows of Suv39h1null mice (n = 7) and WT
littermates (n = 8) (aged 4–6 months). Expression of each repeat relative to Actb has been normalized to the mean value observed in LSK of
WT mice (mean ± SD).
*p < 0.05; **p < 0.01. See also Figure S4.share an identical seed sequence and exert similar effects
on HSC function (Wojtowicz et al., 2014). We found
that the level of mature miR-125b is significantly in-
creased in CD34+CD38 HSC from elderly (>70 years) as
compared with young (<35 years) individuals, a resultthat was confirmed with two independent real-time PCR
assays (Figures 4B and S5A). We also observed a significant
increase in the immature primary miRNA transcript pri-
miR-125b-2, but not pri-miR-125b-1 (Figures 4B and
S5B). An increase was also observed in the levels of matureStem Cell Reports j Vol. 6 j 970–984 j June 14, 2016 975
AB
Figure 4. Expression of miR-125b Increases with Age in Human HSC
(A) Schematic of the 30 UTR of the SUV39H1 mRNA in human (Hsa), mouse (Mmu), and rat (Rno), showing the conserved miR-125 target
sequence (green). Below is shown the sequence of the mature miR-125b (adapted from www.targetscan.org).
(B) Top: Genomic organization (not to scale) of the miRNA cluster containing miR-125b-2 (human chromosome 21q21). The positions of
the amplicons used to detect mature miR-99a, mature miR-125b, and pri-miR-125b-2 are indicated. Bottom: qRT-PCR analysis of mature
miR-125b (left panel), pri-miR-125b-2 (middle panel), and mature miR-99a (right panel) in CD34+CD38 HSC isolated from bone marrows
of young (<35 years) and elderly (>70 years) individuals. Expression of mature miR-125b and 99a (relative to U6) and pri-miR-125b-2
(relative to ACTB) was normalized to the mean value observed in HSC from young individuals (mean ± SD; nR 5).
*p < 0.05; **p < 0.01. See also Figure S5.miR-99a, which is part of a tricistronic cassette with
miR-125b-2 and let-7c on human chromosome 21 (Emm-
rich et al., 2014), suggesting that the entire miR-125b-2
tricistronic cluster is upregulated with age in human
HSC (Figure 4B). We also observed an age-associated
increase in the level of mature miR-125a, although
this miRNA appears to be expressed at lower levels in
CD34+CD38 HSC (Figures S5C and S5D). These findings,
therefore, reveal an age-associated increase in the level of
miR-125 miRNA in human HSC.
To test whether SUV39H1 is indeed a target of miR-125,
we initially ectopically expressed miR-125b in HeLa cells.976 Stem Cell Reports j Vol. 6 j 970–984 j June 14, 2016Transfection of HeLa cells with a miR-125b mimic, a dou-
ble-stranded RNA oligonucleotide mimicking the mature
miRNA, resulted in downregulation of SUV39H1 mRNA
and protein (Figures 5A–5C). We also observed reduced
SUV39H1 expression and decreased enrichment of
H3K9me3 at pericentromeric (SAT II) and dispersed
(HERV/env102) genomic repeats following lentiviral-
mediated expression of miR-125b in HeLa cells (Figures
5D–5F). Consistent with these findings, SUV39H1 has
also been shown to be regulated by miR-125b in murine
muscle cells (Villeneuve et al., 2010) and human hepato-
cellular carcinomas (Fan et al., 2013). To investigate
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Figure 5. SUV39H1 Is a Target of miR-125b
(A–C) HeLa cells were either mock transfected (gray) or transfected with control mimic (black) or miR-125b mimic (red) for 30 hr. qRT-PCR
analysis of mature miR-125b (A) and SUV39H1 mRNA (B) (mean + SD; n = 4). (C) Western blot analysis of SUV39H1 protein in whole-cell
extracts. Left: representative blot. Right: Quantification of SUV39H1 protein relative to b-ACTIN and normalized to the mean value
observed in mock-transfected cells (mean + SD; nR 5).
(D–F) HeLa cells were transduced with a control empty lentiviral vector (expressing mCherry alone, black) or a vector expressing miR-125b
and mCherry (red) for 5–6 days. (D) qRT-PCR analysis of mature miR-125b in mCherry+ HeLa cells (mean + SD; n = 3). (E) ChIP experiments
with anti-H3K9me3 antibody in mCherry+ HeLa cells. Enrichment (bound as a percentage of input) was measured by qPCR at Satellite II
and a Satellite tandem repeats, at HERV-K/env102, and at the promoter of the constitutively expressed b2 microglobulin gene (B2M) as
negative control (mean + SEM; n = 6). (F) Western blot analysis of SUV39H1 protein in whole-cell extracts from mCherry+ HeLa cells. Left:
Representative blot. Right: Quantification of SUV39H1 protein relative to b-ACTIN and normalized to the mean value observed in control-
transduced cells (mean + SD; n = 6).
(G and H) qRT-PCR analysis of the expression of SUV39H1 and mature miR-125b in (G) CD34+CD38 HSC from elderly individuals (>70 years)
treated with miR-125b inhibitor for 24 hr or (H) in cord blood CD34+CD38 HSC treated with miR-125b mimic for 24 hr (mean + SD; nR 4).
(legend continued on next page)
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whether miR-125b also regulates SUV39H1 in HSC,
CD34+CD38 HSC from elderly individuals were treated
with a miR-125b inhibitor, a chemically modified single-
stranded oligonucleotide that interacts with mature miR-
125b. Treatment of aged HSC with the inhibitor resulted
in upregulation of SUV39H1 transcripts indicating that
SUV39H1 is a target of miR-125b in human HSC (Fig-
ure 5G). This was confirmed in a complementary set of ex-
periments where cord blood CD34+CD38 HSC, which
express high levels of SUV39H1 (Figure S1A), were trans-
fected with the miR-125b mimic. After 24 hr with the
miR-125b mimic, expression of SUV39H1 was signifi-
cantly depleted (Figure 5H). Furthermore, overexpression
of miR-125b in CD34+CD38 HSC led to a decrease in
levels of H3K9me3 (Figures 5I and 5J), as well as increased
expression of a subset of genomic repeats (Figure 5K),
indicating a disruption of the normally repressive hetero-
chromatin structure at these elements. Interestingly, the
repeat elements that responded to the miR-125b mimic
(HERV-H/env62 and HERV-K/env102 and Satellite II) were
the same as those whose expression increased with age
in human HSC (Figure 3A). These results demonstrate
that SUV39H1 is targeted by miR-125b in HSC and
that the levels of this miRNA impact upon HSC
heterochromatin.
miR125b Regulates the B Cell Potential of HumanHSC
The above experiments indicate that overexpression of
mir-125b causes similar changes in heterochromatin as
those occurring in aged HSC. To examine the effects of
miR-125b on the differentiation potential of human
HSC, we initially transduced cord blood CD34+CD38
HSC with control or miR-125b-expressing lentiviruses,
and the cells were plated in in vitro differentiation cul-
tures to assess B lymphoid and myeloid output. Overex-
pression of miR-125b resulted in a significant decrease
in the generation of CD19+ B cells and an increase in
CD33+ myeloid cells (Figures 6A and 6B), resulting in an
increased ratio of myeloid to B lymphoid progeny in the
assay (Figure 6C). No changes in differentiation were
observed in the untransduced population (Figures S6A
and S6B). These experiments indicate that, as with age,
overexpression of miR-125b in human HSC leads to(I–J) Cord blood CD34+CD38 HSC were transduced with the contr
PCR analysis of mature miR-125b in mCherry+ cells (mean + SD; n
cells. Results show total cell fluorescence (integrated density) o
experiments).
(K) qRT-PCR analysis of the expression of human endogenous retrovir
env60) and pericentromeric repeats (Satellite II and a Satellite) in cord
24 hr. For each repeat, expression relative to RPLPO has been normal
qRT-PCR results in (A), (B), (D), (G), (H), and (I) are expressed relative
mean value observed in control cells. *p < 0.05; **p < 0.01.
978 Stem Cell Reports j Vol. 6 j 970–984 j June 14, 2016decreased B lymphopoiesis and a myeloid-biased differen-
tiation output.
Inhibition of miR-125 or Overexpression of SUV39H1
Enhances B Lymphoid Differentiation Capacity of
Aged HSC
Finally we investigated whether inhibition of miR-125b or
overexpression of SUV39H1 inHSC fromelderly individuals
improved their capacity to generate B lymphocytes. We first
transduced CD34+CD38 HSC purified from the bone
marrow of elderly individuals (>70 years) with a miR-125
‘‘sponge’’ lentivirus, which expresses a transcript containing
four target sites for miR-125, or a control lentivirus contain-
ing four scrambled target sites. In vitro differentiation
analysis of transduced cells revealed that expression of the
miR-125 sponge in aged HSC resulted in a significant in-
crease in the output of CD19+ B cells and a reduction in the
myeloid:lymphoid ratio (Figures 7A and 7B). No changes
were observed in the untransduced population (Figures
S6C and S6D). We next examined the effect of SUV39H1
overexpression on the differentiation potential of aged
HSC. For these experiments, we generated a lentiviral
construct expressing human SUV39H1 together with GFP.
This lentivirus restored the WT concentration of H3K9me3
at pericentromeric heterochromatin when transduced into
mouseembryonicfibroblasts lackingSUV39H1/2 (FigureS7).
CD34+CD38HSC isolated from the bonemarrowof elderly
individuals were transduced with the empty control (ex-
pressing GFP alone) or SUV39H1 lentivirus, then differenti-
ated in vitro on MS5 stromal cells as above. Similar to the
results obtained following inhibitionofmiR-125, expression
of SUV39H1 in agedHSC increased the generation of CD19+
Bcells andresulted inanoveralldecrease in themyeloid:lym-
phoid differentiation output (Figures 7C and 7D). Again, no
changes were observed in untransduced cells (Figures S6E
and S6F). These experiments show that increasing the
expression of SUV39H1 or inhibition of miR-125 enhances
the capacity of HSC from elderly individuals to generate
B cells and attenuates the age-associatedmyeloid bias. These
findings support the idea that repression of SUV39H1 by
miR-125 and perturbed heterochromatin regulation are
important factors contributing to the decline inB cell poten-
tial of HSC with age.ol (black) or miR-125b (red) lentiviral vector for 72 hr. (I) qRT-
= 6). (J) Immunofluorescence analysis of H3K9me3 in mCherry+
f a minimum of 100 cells (mean ± SD from two independent
al repeats (HERV-H/env62, HERV-K/env102, HERV-H/env59, HERV-H/
blood CD34+CD38 HSC treated with miR-125b mimic or control for
ized to the mean value observed in control (mean ± SD; nR 3).
to U6 for miR-125b or ACTB for SUV39H1 and are normalized to the
AB C
Figure 6. Expression of miR-125b Decreases B Cell Output in Human HSC
(A) Gating strategy and representative flow cytometric profile of progeny derived from cord blood CD34+CD38 HSC transduced with an
empty control lentivirus (expressing mCherry alone) or a lentivirus expressing miR-125b and mCherry and differentiated for 21 days on MS5
stromal cells. Cells were gated initially on expression of hCD45 and mCherry (expressed as a percentage of total live cells). B cells (CD19+)
and myeloid cells (CD33+) are expressed as a percentage of cells within the CD45+mCherry+ gate.
(B) Quantification of the populations shown in (A) at day 7, 15, and 21 of differentiation (mean + SD; n = 6 [day 7] or 12 [days 15 and 21]
from two independent experiments).
(C) Ratio of myeloid to B lymphoid cells within the mCherry+CD45+ population at day 21 of differentiation (mean ± SD; n = 12 from two
independent experiments).
**p < 0.01. See also Figures S6A and S6B.DISCUSSION
Loss of heterochromatin structure and its associated his-
tone mark H3K9me3 have been observed during aging in
many cell types and diverse organisms, leading to the pro-
posal that a decline in heterochromatin integrity may be a
common feature of aging (Tsurumi and Li, 2012). That
age-associated decline of heterochromatin is likely to be
functionally important in driving the aging phenotype in
mammals is strongly supported by the observation that
global loss of heterochromatin markers is a characteristic
feature of the human premature aging disorders, Hutchin-
son-Gilford progeria and Werner syndromes (Shumaker
et al., 2006; Zhang et al., 2015). Furthermore, in model
organisms, it has been shown that the heterochromatin
protein HP1a and the regulation of heterochromatin for-
mation control life span (Larson et al., 2012). Heterochro-
matin has recently been shown to play a key role in the
regulation ofHSCdifferentiation (Ugarte et al., 2015); how-
ever, little was known about the contribution of H3K9me3
and heterochromatin structure to HSC aging. In this study,we show that expression of SUV39H1, a critical factor in
heterochromatin formation, decreases with age in both
human and mouse HSC, leading to widespread changes
in HSC heterochromatin state, and contributing to the
decline in B cell potential observed with advancing age.
Consistent with our observations in HSC, reduced expres-
sion of SUV39H1 and a decrease in global H3K9me3 have
also been observed recently during physiological aging
both in humanmesenchymal stem cells and in immune or-
gans of the rat (Sidler et al., 2013; Zhang et al., 2015). Over-
all, our observations of decreased expression of SUV39H1
and perturbed HSC heterochromatin with age support
recent studies implicating epigenetic change as an impor-
tant driver of the decline in HSC function during aging
(Beerman et al., 2013; Sun et al., 2014).
At present the molecular pathways affected by the
decrease in SUV39H1 and heterochromatin, which con-
tribute to the age-associated changes in HSC function,
are not known. As a critical factor in the establishment
of heterochromatin, SUV39H1 plays an important role in
the maintenance of genome stability. Indeed, hotspots ofStem Cell Reports j Vol. 6 j 970–984 j June 14, 2016 979
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Figure 7. Expression of a miR-125 Sponge and SUV39H1 in Aged HSC Increases B Cell Output and Alleviates Age-Associated
Myeloid Bias
(A) Quantification by FACS of B cells (CD19+) and myeloid cells (CD33+) within the mCherry+CD45+ population at day 7 and 21 of dif-
ferentiation of CD34+CD38 HSC from elderly individuals transduced with the control lentivirus or lentivirus expressing a miR-125 sponge
(mean + SD; n = 5 [day 7] and n = 7 [day 21] from three independent experiments).
(B) Ratio of myeloid to B lymphoid cells within the mCherry+CD45+ population at day 21 of the differentiation in (A) (mean ± SD; n = 7 from
three independent experiments).
(C) Quantification by FACS of B cells (CD19+) and myeloid cells (CD33+) within the GFP+CD45+ population at day 7 and 21 of differentiation
of CD34+CD38 HSC from elderly individuals transduced with empty control- or SUV39H1-lentivirus (mean + SD; n = 6 from three inde-
pendent experiments).
(D) Ratio of myeloid to B lymphoid cells within the GFP+CD45+ population at day 21 of the differentiation in (C) (mean ± SD; n = 6 from
three independent experiments). For all panels, FACS gating and quantification were carried out as in Figure 6.
*p < 0.05; **p < 0.01. See also Figures S6C–S6F and S7.chromosomal translocation breakpoints associated with
hematological malignancy are characterized by depleted
levels of H3K9me3 in human CD34+ cells, and SUV39H1-
mediated deposition of this histone mark has been shown
to directly protect against the formation of DNA double-
strand breaks (Burman et al., 2015). Thus, the age-associated
decline in SUV39H1 shown here could contribute to the
accumulation of double-strand breaks observed in HSC
from elderly individuals and predispose hematopoietic pro-
genitors to increased translocations andmalignant transfor-
mation (Rube et al., 2011; Yahata et al., 2011). In this study,
we also observed a derepression of repeat and retroviral ele-
ments, which could also contribute to genomic instability
(Belgnaoui et al., 2006; Kines et al., 2014), and indeed a
breakdown in the normal transcriptional repression of retro-
transposable elements is emerging as a common character-980 Stem Cell Reports j Vol. 6 j 970–984 j June 14, 2016istic of aging (Gorbunova et al., 2014). Interestingly, recent
evidence suggests that B cell differentiation is particularly
sensitive to transcriptional derepression of endogenous
retroviruses (Collins et al., 2015). Activated genomic repeats
can impact upon the expression of neighboring genes
through the formation of chimeric transcripts (Cruick-
shanks and Tufarelli, 2009; Nigumann et al., 2002). Indeed
enhanced expression of genes proximal to transcriptionally
reactivated repeat elements have been reported both inmu-
rine HSC (Sun et al., 2014) and proB (Collins et al., 2015)
cells, indicating that derepression of repeat elements can
lead to dysregulation of gene-expression programs. Finally,
reduced expression of SUV39H1 could also contribute
directly to the widespread transcriptomic changes that
have been observed inHSCwith age (Pang et al., 2011; Rossi
et al., 2005; Sun et al., 2014) by the upregulation of genes
normally silenced by facultative heterochromatin. This idea
is supported by our findings that the expression of Selp,
one of the most strongly upregulated genes with age in
HSC, is also increased in the hematopoietic progenitors of
Suv39h1null mice.
In this study, we further show that expression of
SUV39H1 in HSC is controlled by the highly conserved
miR-125 miRNA family. While previously shown to be
important regulators of HSC self-renewal and differentia-
tion potential (O’Connell et al., 2010; Ooi et al., 2010),
the contribution of miR-125 members to age-associated
changes in the hematopoietic system had not previously
been investigated. We found that the expression of miR-
125b is increased with age in HSC and that inhibition
of miR-125b leads to increased SUV39H1 expression and
attenuates the myeloid-biased differentiation potential
of HSC from elderly individuals. miRNAs play an impor-
tant role in the regulation of lifespan and aging in model
organisms and a growing body of evidence indicates that
they may also act as regulators of aging pathways in
mammalian tissues (reviewed in Smith-Vikos and Slack,
2012). Indeed a recent study has shown that the miR-
212/132 cluster is upregulated with age in mouse HSC
and that this miRNA can affect HSC function with age
via the regulation of the transcription factor FOXO3
(Mehta et al., 2015). As well as impacting on expression
of SUV39H1, overexpression of the miR-125b-2 tricistron
in HSC has been shown to suppress signaling through
the transforming growth factor b (TGFb) pathway (Emm-
rich et al., 2014). TGFb signaling is a critical regulator
of HSC homeostasis and quiescence (Blank and Karlsson,
2015) and, interestingly, reduced TGFb signaling is a
prominent feature of aging in mouse HSC (Sun et al.,
2014). As well as playing an important role during normal
hematopoiesis, miR-125 has also been implicated as an
oncomir in a number of myeloid and lymphoid leukemias
(Shaham et al., 2012). Thus, the age-associated increase in
miR-125 observed in this study may also contribute to the
enhanced susceptibility to hematological malignancies
observed in the elderly (Sant et al., 2010). At present,
the mechanism driving upregulation of miR-125 with
age in HSC is not known and will require further in-
vestigation. Interestingly, HSC aging is associated with
increased levels of both homeobox factors (Pang et al.,
2011; Sun et al., 2014) and nuclear NF-kB (Chambers
et al., 2007), two transcription factors that have been
shown to be activators of miR-125b expression (Emmrich
et al., 2014; Tan et al., 2012).
In summary, our study has characterized an axis in
which age-associated increase in expression of miR-125b
contributes to a decline in the B cell potential of hu-
man HSC via an effect on SUV39H1 and HSC heterochro-
matin. These findings add to a growing body of evidencedemonstrating that epigenetic change, and in particular
a disruption of heterochromatin integrity, are a general
feature of age-associated tissue decline. The implication
of miR-125 and SUV39H1 in the aging HSC phenotype
presents the possibility of using miR antagonists and
epigenetic modifiers as potential therapeutic approaches
to address the decline in immune function observed in
the elderly.EXPERIMENTAL PROCEDURES
Samples
Cord blood and human bone marrow samples from young (18–
35 years) and elderly (70–98 years) individuals were obtained
from Hoˆpital Saint Louis and Hoˆpital Lariboisie`re, Paris. Young
(2–3 months) and old (20–24 months) C57BL/6 male mice were
purchased from Janvier. Suv39h1null mice (Peters et al., 2001)
were obtained from S. Amigorena (Institute Curie). Details of cell
labeling, FACS sorting, and analysis are described in the Supple-
mental Experimental Procedures.
In Vitro Differentiation Assays
B lymphoid and myeloid differentiation assays were performed as
described in Kuranda et al. (2011) and in the Supplemental Exper-
imental Procedures.
Immunofluorescence Staining
Immunofluorescence staining of human and murine HSC was
performed with anti-H3K9me3 (07-523, Millipore) or anti-HP1a
(MAB3584, Millipore) antibodies as described in the Supplemental
Experimental Procedures.
Statistics
All data are expressed as means and SD except where stated
otherwise. All statistical significance of differences was measured
by unpaired two-tailed Student’s t test (*p < 0.05; **p < 0.01).
Unless stated otherwise, n indicates the number of indepen-
dent experiments performed on HSC isolated from different
pools of two to four individual mouse or human bone marrow
samples.
Study Approval
Ethical approval for the use of human samples was granted by
Institutional Review Board number 00006477 of Paris North Hos-
pitals (approval no. 13-052) and samples were obtained after
informed consent. All animal experiments were performed at the
animal facility of the Institut Universitaire d’He´matologie (no.
B75-10-08) in accordance with the guidelines of the Institutional
Animal Care Committee.
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